Cheribundi

About Cheribundi

Cheribundi operates in the functional beverage market, specializing in tart cherry juice products positioned for natural sports nutrition and recovery. The company was established in 2004, originally as CherryPharm, by John Davey, a former Wall Street banker. Davey collaborated with food scientist Olga Padilla-Zakour at Cornell University's Food Venture Center to create an all-natural tart cherry juice that retains the fruit's beneficial properties. He left his banking career in 2006 to fully dedicate himself to the startup.

The company's business model revolves around the production and sale of tart cherry-based beverages through both retail and direct-to-consumer channels. Its products are distributed in major retailers across the United States, such as Kroger, Publix, and Whole Foods, as well as online. A significant component of its strategy involves supplying its products to the athletic market, with over 400 professional and collegiate sports teams using Cheribundi for recovery and performance. Revenue is generated through the sale of its various product lines. In April 2023, Cheribundi was acquired by NextFoods, the parent company of GoodBelly, though it continues to operate as a distinct brand.

Cheribundi's core offering is a line of tart cherry juice products, developed using a proprietary filtration process designed with Cornell University scientists to maximize antioxidant strength. The product lineup is not-from-concentrate and includes the '100% Tart' version, which contains only tart cherries with no added sugar. Other products include juice concentrates, gummies, and functional blends like 'Immunity,' 'Protein,' and 'Reset,' which incorporate additional ingredients such as echinacea, whey protein, and valerian root. The key benefits marketed to consumers, particularly athletes, are reduced muscle soreness, decreased inflammation, improved sleep due to natural melatonin content, and faster muscle recovery.